Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery

<div>The prognostic value of the HLA-DR+ T cell ratio in AFP-positive HCC patients. Kaplan–Meier curves of PFS (a) and OS (b) for AFP-positive patients with different HLA-DR+ T cell ratio groups.</div>

Journal of Oncology

fig3

Figure 3

Figure 3: Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery 

Figure 3 | Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery 